ARB/CCB combos could be the way ahead for hypertension

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1647, 2008-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sitaxsentan STRIDEs ahead in pulmonary arterial hypertension

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Signalling the way ahead. Receptor Signal Transduction Protocols

By Strosberg A.D.

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 446-446

Elsevier

Access to resources Recommend Favorite

Chalcone and Curcumin Derivatives: A Way Ahead for Malarial Treatment

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2116-2133

Bentham Science Publishers

Access to resources Recommend Favorite

Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy: In US Patients with Hypertension

By Chang Joanne

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 1, 2011-02 ,pp. : 21-32

Adis International

Access to resources Recommend Favorite

ACE inhibitor therapy could be beneficial for many patients with hypertension

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite